Dermorphin UAE | Buy Research-Grade Dermorphin Peptide | ≥99% Purity

Dermorphin is a naturally occurring heptapeptide originally isolated from South American tree frog skin, studied in research settings as one of the most selective and potent mu-opioid receptor agonists known — making it a valuable tool for laboratories investigating opioid receptor pharmacology, pain signalling pathways, and receptor binding mechanisms. Researchers and institutions across the UAE, Dubai, Abu Dhabi and the wider GCC can source verified, research-grade Dermorphin with fast international dispatch and full batch documentation included.

✅ ≥99% Purity — HPLC Verified

✅ Batch-Specific Certificate of Analysis (CoA) Included

✅ Lyophilised Powder | GMP Manufactured

✅ Fast International Dispatch to UAE & GCC

What is Dermorphin?

Dermorphin is a seven-amino-acid peptide (heptapeptide) first isolated in the 1980s from the skin secretions of Phyllomedusa sauvagei, a South American tree frog. What makes it particularly significant in research is its unusual structural feature — it contains a D-amino acid (D-alanine) at position two of its sequence, which is rare in naturally occurring peptides and contributes directly to its high receptor selectivity and resistance to enzymatic degradation compared to many endogenous opioid peptides.

Its exceptional selectivity for mu-opioid receptors (MOR) — reported to be significantly higher than morphine in binding studies — has made Dermorphin a consistently valuable pharmacological research tool for laboratories studying opioid receptor systems, pain pathway mechanisms, and the structure-activity relationships of opioid peptides. Research interest in Dermorphin from institutions across the UAE and GCC reflects the broader global focus on opioid receptor pharmacology and analgesic pathway research.

What Does Dermorphin Do in Research?

In controlled laboratory settings, Dermorphin is studied across several focused research areas:

Mu-Opioid Receptor Pharmacology: Dermorphin’s primary research application is as a highly selective mu-opioid receptor (MOR) agonist. Studies use it to examine MOR binding kinetics, receptor activation mechanisms, downstream signalling cascades, and receptor distribution across tissue types.

Pain Pathway Research: As a potent MOR agonist, Dermorphin is used in pre-clinical models studying nociception — the cellular and molecular basis of pain signalling. Research examines how MOR activation influences pain transmission at various points in the nervous system.

Structure-Activity Relationship (SAR) Studies: Dermorphin’s unusual D-amino acid structure makes it particularly valuable for SAR investigations — studies that examine how specific structural features of a peptide determine its receptor selectivity, binding affinity, and biological activity. These studies help researchers understand what molecular characteristics produce selective opioid receptor engagement.

Receptor Binding Assays: Dermorphin is used as a reference ligand in competitive binding assays examining opioid receptor pharmacology, allowing researchers to characterise other compounds relative to a well-documented, highly selective MOR agonist.

Enzymatic Stability Research: The presence of D-alanine in Dermorphin’s sequence confers resistance to many peptidases, making it a useful model compound for studying how structural modifications affect peptide stability in biological environments.

Comparative Opioid Research: Studies examining differences between opioid receptor subtypes (mu, delta, kappa) frequently use Dermorphin as a selective mu-opioid reference compound to establish comparative pharmacological profiles.

All applications listed are research-based only. Dermorphin is not approved for human therapeutic use and is supplied strictly for controlled laboratory research.

What Do Studies Say About Dermorphin?

Dermorphin has a well-established research profile in opioid pharmacology spanning several decades:

Binding studies have consistently documented Dermorphin’s exceptionally high affinity and selectivity for mu-opioid receptors, with research reporting MOR binding potency significantly greater than morphine in receptor assay models — establishing it as one of the most selective naturally occurring MOR agonists identified to date. SAR research using Dermorphin as a template has produced valuable insights into how D-amino acid incorporation affects peptide receptor selectivity and metabolic stability, informing broader research into peptide-based pharmacological tools. Pre-clinical pain research has used Dermorphin in nociceptive models to characterise mu-opioid receptor-mediated analgesia and examine receptor tolerance and desensitisation mechanisms. Studies examining Dermorphin’s enzymatic resistance have compared its stability profile favourably against endogenous opioid peptides, highlighting the research utility of D-amino acid-containing peptides as stable pharmacological probes. Its well-characterised pharmacological profile has also made it a useful reference compound in studies developing and validating new opioid receptor research tools and assay systems.

Product Specifications

Buying Dermorphin in UAE — What’s Included

Every order of Dermorphin dispatched to the UAE and GCC includes:

• Batch-specific Certificate of Analysis (CoA)
• HPLC Chromatogram
• Mass Spectrometry Confirmation
• Sterility & Endotoxin Testing Report
• Reconstitution Protocol
• Technical Research Support

Frequently Asked Questions — Dermorphin UAE

Can I buy Dermorphin peptide in the UAE?

Yes. We supply research-grade Dermorphin with international dispatch to the UAE, Dubai, Abu Dhabi, Sharjah and across the GCC. All orders include full batch documentation and are packaged to maintain peptide integrity throughout transit. This compound is supplied strictly for laboratory research use only.

Why does Dermorphin contain a D-amino acid?

Dermorphin contains D-alanine at position two of its sequence — an unusual feature for a naturally occurring peptide, as most biological peptides are composed entirely of L-amino acids. This D-amino acid configuration contributes to Dermorphin’s high mu-opioid receptor selectivity and its resistance to enzymatic degradation, both of which make it a particularly useful and stable research tool in opioid pharmacology studies.

How selective is Dermorphin for mu-opioid receptors?

Dermorphin is considered one of the most selective naturally occurring mu-opioid receptor agonists known, with binding studies reporting significantly higher MOR affinity compared to morphine and greater selectivity over delta and kappa opioid receptor subtypes. This selectivity makes it a precise pharmacological tool for studies requiring specific MOR engagement without significant off-target receptor activity.

What purity is required for Dermorphin research?

A minimum of ≥98% is considered research grade, though ≥99% is strongly preferred for receptor binding assays, SAR studies, and nociceptive research models where compound purity directly affects the reliability of pharmacological measurements. All our Dermorphin is independently verified to ≥99%.

How is Dermorphin reconstituted for laboratory use?

Allow the vial to reach room temperature before opening. Add sterile water, dilute acetic acid solution, or DMSO slowly depending on your protocol requirements, and swirl gently without shaking. Aliquot immediately if longer-term storage at -80°C is required to preserve integrity and avoid freeze-thaw degradation.

How quickly is Dermorphin delivered to UAE?

Orders are dispatched promptly via tracked international courier. Delivery to the UAE typically takes 3–5 working days, with packaging designed to maintain peptide stability throughout transit.

Research Disclaimer: Dermorphin is supplied exclusively for legitimate scientific research purposes conducted within licensed laboratory environments. This product is not intended for human consumption, self-administration, or any therapeutic application. It must be handled by qualified researchers in strict compliance with applicable UAE regulations, institutional ethics guidelines, and all relevant controlled substances legislation. Handling should only be performed by qualified laboratory professionals in controlled research settings with appropriate authorisations in place. By purchasing, you confirm that this compound will be used solely for approved in-vitro or pre-clinical research purposes.